Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

Lead HIV Drug Selected to Progress Into Human Trials

2 May 20138 September 2005 by Karen Mobbs

Lead HIV Drug Selected to Progress Into Human Trials

Categories 2005
Biotron Compound Active Against Resistant HIV
Preliminary Final Report for year ended 30 June 2005
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 6 June 2025        Legal Notices and Privacy
Cleantalk Pixel